Sigma-Tau Pharmaceuticals, Inc.

Two words to encapsulate the core principles of an entire company. Sigma-Tau Pharmaceuticals, Inc. is a rare corporation dedicated to creating novel therapies for the unmet needs of patients with rare diseases. Truly unique in its field, Sigma-Tau places its considerable scientific resources behind the discovery of compounds that benefit the few. Simply because it's the right thing to do. By maintaining an environment based on integrity, honesty, and placing the patient first, Sigma-Tau is able to consider what may be a small commercial success nothing less than a human triumph. To us, there is no greater accomplishment than helping the little girl who is suffering from corneal cystinosis or the man with Hodgkin's lymphoma. After all, to Sigma-Tau, there's no difference between a disease that affects 300 or 300,000,000.

Contact Details: 9841 Washingtonian Blvd Suite 500 Gaithersburg Maryland MD 20878 United States of America Tel: 1 (800) 447-0169 Fax: 1 (301) 948-1862 Email: sigmatauinfo@sigmatau.com WWW: www.sigmatau.com

Loading...

Press Releases on Sigma-Tau Pharmaceuticals, Inc.:
DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments	15th May, 2009	DOR BioPharma, Inc.	PRINCETON, N.J., May 15 /PRNewswire-FirstCall/ -- DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biopharmaceutical company, today announced its financial results for
Sigma-Tau Pharmaceuticals and Danisco BioActives Announce Partnership Agreement to Develop Drug Candidate for Prevention of Necrotizing Enterocolitis	7th April, 2009	Sigma-Tau Pharmaceuticals	GAITHERSBURG, Md., April 7 /PRNewswire/ -- Sigma-Tau Pharmaceuticals, Inc. and Danisco BioActives announced today that they have signed a partnering agreement for the development of a new biologic
DOR BioPharma Reports Year-End 2008 Financial Results and Reviews Recent Accomplishments	31st March, 2009	DOR BioPharma, Inc.	PRINCETON, N.J., March 31 /PRNewswire-FirstCall/ -- DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biopharmaceutical company, today announced its financial results
DOR BioPharma Appoints Gregg Lapointe, CPA, MBA, to its Board of Directors	16th March, 2009	DOR BioPharma, Inc.	EWING, N.J., March 16 /PRNewswire-FirstCall/ -- DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company) announced today that it has appointed Gregg Lapointe, CPA, MBA, to its Board of
DOR BioPharma Announces Potential $30 Million North American Partnership Agreement with Sigma-Tau Pharmaceuticals for orBec(R) in the Treatment of Graft-versus-Host Disease	12th February, 2009	DOR BioPharma, Inc.	EWING, N.J., Feb. 12 /PRNewswire-FirstCall/ -- DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company) announced today that it has signed a potential $30 million partnering agreement with

BioNews Results for Sigma-Tau Pharmaceuticals, Inc.:
Soligenix Reports Third Quarter 2009 Financial Results	KOTA Territory News:  Nov 14 2009 11:05PM Matching: sigma tau pharmaceuticals inc
Soligenix Reports Third Quarter 2009 Financial Results	KSLA:  Nov 14 2009 7:28AM Matching: sigma tau pharmaceuticals inc
Soligenix Reports Third Quarter 2009 Financial Results	Ulitzer:  Nov 13 2009 9:09PM Matching: sigma tau pharmaceuticals inc
Third quarter 2009 financial results announced by Soligenix	News-Medical.Net:  Nov 13 2009 1:15PM Matching: sigma tau pharmaceuticals inc
Soligenix Reports Third Quarter 2009 Financial Results	Genetic Engineering News:  Nov 13 2009 12:57PM Matching: sigma tau pharmaceuticals inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Sigma-Tau Pharmaceuticals, Inc. news.

Sigma-Tau Pharmaceuticals, Inc. Patents:
US Patent No.	Title
7333894	Methods for the diagnosis of hemodialysis patients and utilization of such methods to improve the administration of intravenous levocarnitine treatments to hemodialysis patients
7011977	Quantification of carnitine levels in dialysis patients
5958886	Carnitine-containing peptides and a method for using the same
5686491	Infant formula

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 492 times since April 2007, the link to the organisation's website has been followed 76 times

Recent Search Terms used to find this page: sigma tau pharmaceuticals | sigma tau pharma 2008 financials | sigma tau pharmaceuticals inc | sigma pharmaceuticals sigma-tau | Sigma-Tau financials | .

Search for more companies in Gaithersburg

Search for more companies in Maryland

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Sigma-Tau Pharmaceuticals, Inc.